Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

This study is ongoing, but not recruiting participants.

Study NCT00599885 Information provided by Korea University Anam Hospital

First Received: January 11, 2008 Last Updated: June 30, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2008 (Final data collection date for primary outcome measure)

No publications provided by Korea University Anam Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Hong SJ, Choi SC, Ahn CM, Park JH, Kim JS, Lim DS. Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients. Heart. 2011 Sep;97(17):1425-32. Epub 2011 Jun 23.